Related Experiment Video
Updated: Apr 30, 2026
08:58
Matrix-assisted Autologous Chondrocyte Transplantation for Remodeling and Repair of Chondral Defects in a Rabbit Model
Published on: May 21, 2013
13.9K
Tissue-engineered cartilage with inducible and tunable immunomodulatory properties
Katherine A Glass1, Jarrett M Link1, Jonathan M Brunger1
1Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC 27710, USA; Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
Biomaterials
|April 29, 2014
Summary
Engineered cartilage overexpressing interleukin-1 receptor antagonist (IL-1Ra) promotes chondrogenesis despite high IL-1 levels. This functional tissue engineering approach offers a promising therapy for osteoarthritis and cartilage repair.
Area of Science:
- Regenerative Medicine
- Biotechnology
- Osteoarthritis Research
Background:
- Osteoarthritis pathogenesis involves inflammatory cytokines like interleukin-1 (IL-1).
- IL-1 inhibits human mesenchymal stem cell (MSC) chondrogenesis and promotes cartilage degradation.
- Current treatments for osteoarthritis often lack long-term efficacy in addressing cartilage damage.
Purpose of the Study:
- To develop engineered cartilage with immunomodulatory properties for chondrogenesis in IL-1-rich environments.
- To utilize gene therapy to induce overexpression of IL-1 receptor antagonist (IL-1Ra) in MSCs within engineered cartilage.
- To create a functional tissue-engineered construct capable of delivering therapeutic levels of IL-1Ra.
Main Methods:
- Scaffold-mediated lentiviral gene delivery to transduce MSCs with a doxycycline-inducible IL-1Ra vector.
- Culture of transduced MSCs in monolayer and within 3D woven polycaprolactone (PCL) scaffolds.
- Assessment of chondrogenesis, extracellular matrix production, matrix metalloproteinase activity, and mechanical properties in the presence of IL-1.
Main Results:
- Engineered cartilage with IL-1Ra expression successfully underwent chondrogenesis despite pathologic IL-1 levels.
- IL-1Ra-expressing constructs produced cartilage-specific extracellular matrix and maintained native-like mechanical properties.
- The engineered cartilage resisted IL-1-induced upregulation of matrix metalloproteinases.
Conclusions:
- Gene therapy combined with functional tissue engineering can create resilient engineered cartilage.
- Tunable IL-1Ra delivery from engineered cartilage can restore chondrogenesis and protect cartilage in inflammatory conditions.
- This approach holds potential for enhancing long-term success in treating cartilage injuries and osteoarthritis.
